Skip to content

G7® Longevity® 20123204Recalls & reported problems

Zimmer, Inc. · Class 2 · Implant

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00889024519268), received between Jan 31, 2023 and Aug 26, 2025 — classified as 4 injuries.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Device Dislodged or Dislocated1

Patient problems

  • Hematoma2
  • Unspecified Infection2
  • Bacterial Infection1
  • Bursitis1
  • Fall1
  • Joint Dislocation1
  • Pain1
  • Post Operative Wound Infection1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 26, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    NO ADDITIONAL INFORMATION AVAILABLE FOR THE REPORTED EVENT.

    Patient problems: Bursitis; Pain

    MAUDE report 22893085 ↗
  • InjuryJul 1, 2024Device Dislodged or Dislocated; Device Dislodged or Dislocated

    IT WAS REPORTED THAT APPROXIMATELY TWO YEARS POST IMPLANTATION OF A LEFT TOTAL HIP ARTHROPLASTY AND INCISION AND DRAINAGE FOR EXCESSIVE DRAINAGE AND HEMATOMA REQUIRING JOINT DEBRIDEMENT, THE PATIENT WAS REVISED DUE TO DISLOCATION. WHILE THE PATIENT WAS IN 6 INCHES OF WATER BENT OVER AT WAIST, THE LEFT HIP DISLOCATED. THE PATIENT SUBSEQUENTLY HAD A CLOSED REDUCTION IN THE EMERGENCY ROOM. THE PATIENT HAD A FOLLOW UP APPOINTMENT THREE DAYS LATER AND GIVEN A BRACE. NO ADDITIONAL INFORMATION AVAILABLE.

    Patient problems: Fall; Joint Dislocation

    MAUDE report 19651130 ↗
  • InjuryFeb 2, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THE PATIENT UNDERWENT A LEFT HIP REVISION APPROXIMATELY ONE MONTH POST IMPLANTATION DUE TO A POST-OP HEMATOMA AND DRAINING SINUS. THIS REQUIRED AN INCISION, DRAINAGE, ANTIBIOTICS AND JOINT DEBRIDEMENT. CONCLUDING THIS PROCEDURE, AN UNSPECIFIED INFECTION WAS NOTED. THE PATIENT WAS TREATED WITH IV ANTIBIOTICS. APPROXIMATELY A MONTH LATER THE PATIENT EXPERIENCE CONTINUED WOUND DRAINAGE AND SIGNS OF AN INFECTION. THE PATIENT WAS COVID POSITIVE AND UNDERWENT A SECOND IRRIGATION AND DEBRIDEMENT ALONG WITH REPLACEMENT OF THE HEAD AND LINER. CULTURES FROM THIS REVISION SURGERY WERE POSITIVE FOR INFECTION AND PATIENT CONTINUED IV ANTIBIOTICS ALONG WITH FOLLOW UP CARE FROM AN INFECTIOUS DISEASE SPECIALIST.

    Patient problems: Bacterial Infection; Hematoma; Post Operative Wound Infection; Unspecified Infection

    MAUDE report 16284961 ↗
  • InjuryJan 31, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT UNDERWENT LEFT HIP JOINT DEBRIDEMENT APPROXIMATELY TWO WEEKS POST IMPLANTATION DUE TO EXCESSIVE DRAINAGE AND HEMATOMA. SUBSEQUENTLY, FIVE WEEKS POST-OP, THE PATIENT EXPERIENCED DELAYED HEALING OF THE LEFT TOTAL HIP ARTHROPLASTY WOUND. THE SURGEON UTILIZED THE PREVIOUS INCISION AND PERFORMED AN ARTHROTOMY. THE INCISION WAS ENTIRELY INTACT EXCEPT FOR A PIN HOLE AT THE CENTRAL PORTION. ONCE THE PIN HOLE WAS DISSECTED, THE SURGEON ENCOUNTERED A FLUID COLLECTION IN THE SUBCUTANEOUS REGION WITH A SMALL AMOUNT OF FATTY NECROSIS AND THE PRESENCE OF SEROUS FLUID. THREE CULTURES WERE OBTAINED AND SENT TO PATHOLOGY. THE WOUND WAS IRRIGATED AND DEBRIDED, AND THERE WAS NO PURULENCE OR EVIDENCE OF FRANK INFECTION PRESENT. A FORMAL ARTHROTOMY WAS THEN PERFORMED TO ENSURE ADEQUATE IRRIGATION AND DEBRIDEMENT WITH INTACT IMPLANTS NOTED. THE SURGEON REPORTED THAT THE EVENT WAS PROBABLY RELATED TO PROCEDURE; NOT RELATED TO DEVICE AND OR INSTRUMENTS. THE PATIENT HAD BEEN RECEIVING ROCEPHIN BUT WAS SWITCHED TO IV DAPTOMYCIN DUE TO RASH FROM ROCEPHIN. APPROXIMATELY ONE WEEK POST ARTHROTOMY, THE PATIENT WAS EVALUATED AT THE ER FOR DYSPNEA, TACHYCARDIA AND LEFT LEG PAIN. A

    Patient problems: Hematoma; Pulmonary Embolism; Unspecified Infection

    MAUDE report 16272641 ↗

Other Hip, semi-constrained, cemented, metal/ceramic/polymer + additive, porous uncemented devices

All Hip, semi-constrained, cemented, metal/ceramic/polymer + additive, porous uncemented devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.